The DOI matches its Crossref record; 117 of the 117 references it cites were found in a registry or an index.
Scorpion venom components as potential candidates for drug development
Open accessAbstract
Scorpions are well known for their dangerous stings that can result in severe consequences for human beings, including death. Neurotoxins present in their venoms are responsible for their toxicity. Due to their medical relevance, toxins have been the driving force in the scorpion natural compounds research field. On the other hand, for thousands of years, scorpions and their venoms have been applied in traditional medicine, mainly in Asia and Africa. With the remarkable growth in the number of characterized scorpion venom components, several drug candidates have been found with the potential to tackle many of the emerging global medical threats. Scorpions have become a valuable source of biologically active molecules, from novel antibiotics to potential anticancer therapeutics. Other venom components have drawn attention as useful scaffolds for the development of drugs. This review summarizes the most promising candidates for drug development that have been isolated from scorpion venoms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,293
Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies
Hancock, R. E. W., & Sahl, H.-G. (2006) · Nature Biotechnology · doi:10.1038/nbt1267 · Cited by 4,208
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174 · cited 2×
“Pandinin2 can inhibit the growth of Candida albicans (Pfaller and Diekema, 2007)”
BackgroundInfluentialChargaff, E., & Davidson, J. N. (1955) · Cited by 2,043
Designing antimicrobial peptides: form follows function
Fjell, C. D., Hiss, J. A., Hancock, R. E. W., & Schneider, G. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3591 · Cited by 2,035
Molecular Mechanisms of Antibacterial Multidrug Resistance
Alekshun, M. N., & Levy, S. B. (2007) · Cell · doi:10.1016/j.cell.2007.03.004 · Cited by 1,647
GLOBOCAN 2008 v1.2, Cancer incidence and mortality world-wide : IARC Cancer Base No. 10
Ferlay, J. (2010) · Medical Entomology and Zoology · Cited by 1,633
Global malaria mortality between 1980 and 2010: a systematic analysis
Murray, C. J., Rosenfeld, L. C., Lim, S. S., Andrews, K. G., Foreman, K. J., Haring, D., Fullman, N., Naghavi, M., Lozano, R., & Lopez, A. D. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60034-8 · Cited by 1,452 · cited 1×
“Children in subSaharan Africa and Southeast Asia have the highest risk of contracting and dying from malaria (Murray et al., 2012).”
BackgroundWhite, N. J., Pukrittayakamee, S., Hien, T. T., Faiz, M. A., Mokuolu, O. A., & Dondorp, A. M. (2014) · The Lancet · doi:10.1016/s0140-6736(13)60024-0 · Cited by 1,123
APD2: the updated antimicrobial peptide database and its application in peptide design.
Wang, G., Li, X., & Wang, Z. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn823 · Cited by 941
Epidemiology of scorpionism: A global appraisal
Chippaux, J.-P., & Goyffon, M. (2008) · Acta Tropica · doi:10.1016/j.actatropica.2008.05.021 · Cited by 750
From antimicrobial to anticancer peptides. A review
Gaspar, D., Veiga, A. S., & Castanho, M. A. R. B. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00294 · Cited by 749
Voltage-gated K+ channels in human T lymphocytes: a role in mitogenesis?
DeCoursey, T. E., Chandy, K. G., Gupta, S., & Cahalan, M. D. (1984) · Nature · doi:10.1038/307465a0 · Cited by 744
Polis, G. A. (1990) · Medical Entomology and Zoology · Cited by 718
Galvez, A., Gimenez-Gallego, G., Reuben, J. P., Roy-Contancin, L., Feigenbaum, P., Kaczorowski, G. J., & Garcia, M. L. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38560-6 · Cited by 702
Alpha-helical cationic antimicrobial peptides: relationships of structure and function
Huang, Y., Huang, J., & Chen, Y. (2010) · Protein & Cell · doi:10.1007/s13238-010-0004-3 · Cited by 575
Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases
Beeton, C., Wulff, H., Standifer, N. E., Azam, P., Mullen, K. M., Pennington, M. W., Kolski-Andreaco, A., Wei, E., Grino, A., Counts, D. R., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605136103 · Cited by 538
Mookherjee, N., & Hancock, R. E. W. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-6475-6 · Cited by 462
K+ channels as targets for specific immunomodulation
George Chandy, K., Wulff, H., Beeton, C., Pennington, M., Gutman, G. A., & Cahalan, M. D. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.03.010 · Cited by 427
Chlorotoxin Inhibits Glioma Cell Invasion via Matrix Metalloproteinase-2
Deshane, J., Garner, C. C., & Sontheimer, H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m205662200 · Cited by 415
DeBin, J. A., Maggio, J. E., & Strichartz, G. R. (1993) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1993.264.2.c361 · Cited by 407
Rodríguez de la Vega, R. C., & Possani, L. D. (2005) · Toxicon · doi:10.1016/j.toxicon.2005.09.006 · Cited by 372
Self-citationNew antibiotic agents in the pipeline and how they can help overcome microbial resistance
Gould, I. M., & Bal, A. M. (2013) · Virulence · doi:10.4161/viru.22507 · Cited by 363
Garcia-Calvo, M., Leonard, R. J., Novick, J., Stevens, S. P., Schmalhofer, W., Kaczorowski, G. J., & Garcia, M. L. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)46707-x · Cited by 345
High levels of stromal hyaluronan predict poor disease outcome in epithelial ovarian cancer.
Anttila, M., Tammi, R., Tammi, M., Syrjänen, K. J., Saarikoski, S., & Kosma, V. (2000) · PubMed · Cited by 327
Beeton, C., Wulff, H., Barbaria, J., Clot-Faybesse, O., Pennington, M., Bernard, D., Cahalan, M. D., Chandy, K. G., & Béraud, E. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241497298 · Cited by 318
Regulation of multidrug resistance in pathogenic fungi
Morschhäuser, J. (2010) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2009.08.002 · Cited by 300 · cited 2×
“Fungi can become resistant to antifungal drugs by specific mechanisms or by more generic ones, e.g., by actively transporting them out of the cell through multidrug efflux pumps (Morschhauser, 2010).”
BackgroundNatural roles of antimicrobial peptides in microbes, plants and animals
Maróti, G., Kereszt, A., Kondorosi, É., & Mergaert, P. (2011) · Research in Microbiology · doi:10.1016/j.resmic.2011.02.005 · Cited by 298
Scorpine, an anti‐malaria and anti‐bacterial agent purified from scorpion venom
Conde, R., Zamudio, F. Z., Rodrı́guez, M. H., & Possani, L. D. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01384-3 · Cited by 290
Self-citationIsbister, G. K., & Bawaskar, H. S. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1401108 · Cited by 288
Gimenez-Gallego, G., Navia, M. A., Reuben, J. P., Katz, G. M., Kaczorowski, G. J., & Garcia, M. L. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.10.3329 · Cited by 286
Development of Transgenic Fungi That Kill Human Malaria Parasites in Mosquitoes
Fang, W., Vega-Rodríguez, J., Ghosh, A. K., Jacobs-Lorena, M., Kang, A., & St. Leger, R. J. (2011) · Science · doi:10.1126/science.1199115 · Cited by 280
Scorpion Venom and the Inflammatory Response
Petricevich, V. L. (2010) · Mediators of Inflammation · doi:10.1155/2010/903295 · Cited by 273
Mamelak, A. N., & Jacoby, D. B. (2007) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.4.2.175 · Cited by 273
Lyons, S. A., O'Neal, J., & Sontheimer, H. (2002) · Glia · doi:10.1002/glia.10083 · Cited by 263
The contribution of cytotoxic chemotherapy to 5-year survival in adult malignancies
Morgan, G., Ward, R., & Barton, M. (2004) · Clinical Oncology · doi:10.1016/j.clon.2004.06.007 · Cited by 221
Blockade of the voltage-gated potassium channel Kv1.3 inhibits immune responses in vivo
Koo, G. C., Blake, J. T., Talento, A., Nguyen, M., Lin, S., Sirotina, A., Shah, K., Mulvany, K., Hora, D., Cunningham, P., et al. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.11.5120 · Cited by 219
Mamelak, A. N., Rosenfeld, S., Bucholz, R., Raubitschek, A., Nabors, L. B., Fiveash, J. B., Shen, S., Khazaeli, M. B., Colcher, D., Liu, A., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.4569 · Cited by 218
Hadrurin, a new antimicrobial peptide from the venom of the scorpion Hadrurus aztecus
Torres‐Larios, A., Gurrola, G. B., Zamudio, F. Z., & Possani, L. D. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01556.x · Cited by 206
Self-citationAntimicrobial and cytolytic peptides of venomous arthropods
Kuhn-Nentwig, L. (2003) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s00018-003-3106-8 · Cited by 205
Rinaldi, M. G. (1983) · Clinical Infectious Diseases · doi:10.1093/clinids/5.6.1061 · Cited by 200
Scorpion venom peptides with no disulfide bridges: A review
Almaaytah, A., & Albalas, Q. (2014) · Peptides · doi:10.1016/j.peptides.2013.10.021 · Cited by 193
Beeton, C., Barbaria, J., Giraud, P., Devaux, J., Benoliel, A.-M., Gola, M., Sabatier, J. M., Bernard, D., Crest, M., & Béraud, E. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.2.936 · Cited by 191
Antimicrobial peptides from scorpion venoms
Harrison, P. L., Abdel-Rahman, M. A., Miller, K., & Strong, P. N. (2014) · Toxicon · doi:10.1016/j.toxicon.2014.06.006 · Cited by 190
Voltage-gated sodium channel modulation by scorpion α-toxins
Bosmans, F., & Tytgat, J. (2007) · Toxicon · doi:10.1016/j.toxicon.2006.09.023 · Cited by 179
Moerman, L., Bosteels, S., Noppe, W., Willems, J., Clynen, E., Schoofs, L., Thevissen, K., Tytgat, J., Van Eldere, J., van der Walt, J., et al. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.03177.x · Cited by 178
Scorpion Venom Peptides without Disulfide Bridges
Zeng, X.-C., Corzo, G., & Hahin, R. (2005) · IUBMB Life (International Union of Biochemistry and Molecular Biology: Life) · doi:10.1080/15216540500058899 · Cited by 169
Candida tropicalisin human disease
Chai, L. Y. A., Denning, D. W., & Warn, P. A. (2010) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2010.489506 · Cited by 164
Heinen, T. E., & da Veiga, A. B. G. (2011) · Toxicon · doi:10.1016/j.toxicon.2011.01.002 · Cited by 163
Bradykinin-potentiating peptides: Beyond captopril
de Camargo, A. C. M., Ianzer, D. A., Guerreiro, J. R., & Serrano, S. M. T. (2011) · Toxicon · doi:10.1016/j.toxicon.2011.07.013 · Cited by 162
KCNMA1 gene amplification promotes tumor cell proliferation in human prostate cancer
Bloch, M., Ousingsawat, J., Simon, R., Schraml, P., Gasser, T. C., Mihatsch, M. J., Kunzelmann, K., & Bubendorf, L. (2006) · Oncogene · doi:10.1038/sj.onc.1210036 · Cited by 154
Valdivia, H. H., Kirby, M. S., Lederer, W. J., & Coronado, R. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12185 · Cited by 151
Serum levels of cytokines in patients envenomed by Tityus serrulatus scorpion sting
de Magalhaes, M. M., Pereira, M. E. S., Amaral, C. F. S., de Rezende, N. A., Campolina, D., Bucaretchi, F., Gazzinelli, R. T., & Cunha-Melo, J. R. (1999) · Toxicon · doi:10.1016/s0041-0101(98)00251-7 · Cited by 138
Costa, P. M., Cardoso, A. L., Mendonça, L. S., Serani, A., Custódia, C., Conceição, M., Simões, S., Moreira, J. N., de Almeida, L. P., & de Lima, M. C. P. (2013) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2013.30 · Cited by 138
Han, S. H., Yin, S., Yin, S.-J., Chen, Z., Liu, H., Cao, Z., Wu, Y., & Li, W. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802054200 · Cited by 134
Antibacterial Activity and Mechanism of a Scorpion Venom Peptide Derivative In Vitro and In Vivo
Cao, L., Chao, D., Li, Z., Fan, Z., Song, Y., Wu, Y., Cao, Z., & Li, W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040135 · Cited by 133
Zeng, X., Wang, S.-X., Zhu, Y., Zhu, S., & Li, W. (2004) · Peptides · doi:10.1016/j.peptides.2003.12.003 · Cited by 133
Anti-proliferative effect of Kv1.3 blockers in A549 human lung adenocarcinoma in vitro and in vivo
Jang, S. H., Choi, S. Y., Ryu, P. D., & Lee, S. Y. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.10.066 · Cited by 133
Fajloun, Z., Kharrat, R., Chen, L., Lecomte-Pradines, C., di Luccio, E., Bichet, D., Ayeb, M. E., Rochat, H., Allen, P. D., Pessah, I. N., et al. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01239-4 · Cited by 129
K+ channel types targeted by synthetic OSK1, a toxin fromOrthochirus scrobiculosusscorpion venom
Mouhat, S., Visan, V., Ananthakrishnan, S., Wulff, H., Andreotti, N., Grissmer, S., Darbon, H., WAARD, M. M. D., & Sabatier, J. (2004) · Biochemical Journal · doi:10.1042/bj20041379 · Cited by 124
Yu, X., Liang, L., Wang, X., Wang, J., Zhang, X., & Zhang, Q. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.03.014 · Cited by 122
Role for calcium‐activated potassium channels (BK) in growth control of human malignant glioma cells
Weaver, A. K., Liu, X., & Sontheimer, H. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20240 · Cited by 121
Valverde, P., Kawai, T., & Taubman, M. A. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.0301213 · Cited by 110
Mucroporin, the First Cationic Host Defense Peptide from the Venom ofLychas mucronatus
Chao, D., Ma, Y., Zhao, Z., Zhao, R., Wang, Q., Wu, Y., Cao, Z., & Li, W. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00542-08 · Cited by 109
Zoccal, K. F., Bitencourt, C. D. S., Paula‐Silva, F. W. G., Sorgi, C. A., Bordon, K. D. C. F., Arantes, E. C., & Faccioli, L. H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088174 · Cited by 107
Expression of voltage-activated chloride currents in acute slices of human gliomas
Ullrich, N. J., Bordey, A., Gillespie, G. Y., & Sontheimer, H. W. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00456-9 · Cited by 107
K+ Channel Blockers: Novel Tools to Inhibit T Cell Activation Leading to Specific Immunosuppression
Panyi, G., Possani, L. D., Vega, R. C., Gáspár, R., & Varga, Z. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206777585120 · Cited by 103
Self-citationGupta, S. D., Debnath, A., Saha, A., Giri, B., Tripathi, G., Vedasiromoni, J. R., Gomes, A., & Gomes, A. (2006) · Leukemia Research · doi:10.1016/j.leukres.2006.06.004 · Cited by 101
Gupta, S. D., Gomes, A., Debnath, A., Saha, A., & Gomes, A. (2009) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2009.11.006 · Cited by 99
Emergence of Saccharomyces cerevisiae as a human pathogen
Murphy, A., & Kavanagh, K. (1999) · Enzyme and Microbial Technology · doi:10.1016/s0141-0229(99)00086-1 · Cited by 98 · cited 2×
“Opistoporin 1 and parabutoporin inhibited 50% growth (IC50) of the yeast Saccharomyces cerevisiae (Murphy and Kavanagh, 1999) at a concentration of 2 mM (Moerman et al., 2002).”
BackgroundAlmaaytah, A. M., Zhou, M., Wang, L., Chen, T., Walker, B., & Shaw, C. (2012) · Peptides · doi:10.1016/j.peptides.2012.03.016 · Cited by 98
Characterization of two linear cationic antimalarial peptides in the scorpion Mesobuthus eupeus
Gao, B., Xu, J., Rodriguez, M. D. C., Lanz‐Mendoza, H., Hernández‐Rivas, R., Du, W., & Zhu, S. (2010) · Biochimie · doi:10.1016/j.biochi.2010.01.011 · Cited by 98
Anti-HIV-1 Activity of a New Scorpion Venom Peptide Derivative Kn2-7
Chen, Y.-Q., Cao, L., Zhong, M., Zhang, Y., Chen, H., Li, Q., Yang, J., Zhou, D., Shi, W. K., He, B., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034947 · Cited by 94
Imaging glioma extent with 131I-TM-601.
Hockaday, D. C., Shen, S., Fiveash, J. B., Raubitschek, A. A., Colcher, D. M., Liu, A., Alvarez, V. L., & Mamelak, A. N. (2005) · PubMed · Cited by 90
Imcroporin, a New Cationic Antimicrobial Peptide from the Venom of the Scorpion Isometrus maculates
Zhao, Z., Ma, Y., Chao, D., Zhao, R., Li, S., Wu, Y., Cao, Z., & Li, W. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01436-08 · Cited by 88
Biophysical and pharmacological characterization of chloride currents in human astrocytoma cells
Ullrich, N. J., & Sontheimer, H. W. (1996) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1996.270.5.c1511 · Cited by 86
Invasion of human glioma cells is regulated by multiple chloride channels including ClC-3.
Lui, V. C. H., Lung, S. S. S., Pu, J. K. S., Hung, K. N., & Leung, G. (2010) · PubMed · Cited by 86
Gao, B., Sherman, P., Luo, L., Bowie, J. H., & Zhu, S. (2008) · The FASEB Journal · doi:10.1096/fj.08-122317 · Cited by 85
A new natural α-helical peptide from the venom of the scorpion Heterometrus petersii kills HCV
Yan, R., Zhao, Z., He, Y., Wu, L., Cai, D., Hong, W., Wu, Y., Cao, Z., Zheng, C., & Li, W. (2010) · Peptides · doi:10.1016/j.peptides.2010.10.008 · Cited by 84
Aroui, S., Ram, N., Appaix, F., Ronjat, M., Kénani, A., Pirollet, F., & WAARD, M. M. D. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9782-1 · Cited by 82
In Vivo Bio-imaging Using Chlorotoxin-based Conjugates
Stroud, M. R., Hansen, S. J., & Olson, J. M. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211798999375 · Cited by 82
K+ Channel-Dependent Migration of Fibroblasts and Human Melanoma Cells
Schwab, A., Reinhardt, J., Schneider, S. W., Gaßner, B., & Schuricht, B. (1999) · Cellular Physiology and Biochemistry · doi:10.1159/000016309 · Cited by 79
Feng, L., Gao, R., & Gopalakrishnakone, P. (2008) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2008.06.003 · Cited by 77
A designer ligand specific for Kv1.3 channels from a scorpion neurotoxin-based library
Takacs, Z., Toups, M., Kollewe, A., Johnson, E. C. B., Cuello, L. G., Driessens, G., Biancalana, M., Koide, A., Ponte, C. G., Perozo, E., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910123106 · Cited by 77
Zeng, X., Wang, S., Nie, Y., Zhang, L., & Luo, X. (2011) · Peptides · doi:10.1016/j.peptides.2011.11.012 · Cited by 76
Fan, Z., Cao, L., He, Y., Hu, J., Di, Z., Wu, Y., Li, W., & Cao, Z. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00369-11 · Cited by 72
Three new antimicrobial peptides from the scorpion Pandinus imperator
Zeng, X., Zhou, L., Shi, W., Luo, X., Zhang, L., Nie, Y., Wang, J., Wu, S., Cao, B., & Cao, H. (2013) · Peptides · doi:10.1016/j.peptides.2013.03.026 · Cited by 71
Vejovine, a new antibiotic from the scorpion venom of Vaejovis mexicanus
Hernández-Aponte, C. A., Silva-Sánchez, J., Quintero‐Hernández, V., Rodríguez‐Romero, A., Balderas, C., Possani, L. D., & Gurrola, G. B. (2010) · Toxicon · doi:10.1016/j.toxicon.2010.10.008 · Cited by 69
Self-citationBmKCT toxin inhibits glioma proliferation and tumor metastasis
Fan, S., Sun, Z., Jiang, D., Chao, D., Ma, Y., Zhao, Z., Liu, H., Wu, Y., Cao, Z., & Li, W. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.10.011 · Cited by 69
García, F., Villegas, E., Espino-Solís, G. P., Rodríguez, A., Paniagua-Solís, J., Sandoval-Lopez, G., Possani, L. D., & Corzo, G. A. (2012) · The Journal of Antibiotics · doi:10.1038/ja.2012.87 · Cited by 67
Self-citationBK channel blockers inhibit potassium-induced proliferation of human astrocytoma cells
Basrai, D., Kraft, R., Bollensdorff, C., Liebmann, L., Benndorf, K., & Patt, S. (2002) · Neuroreport · doi:10.1097/00001756-200203250-00008 · Cited by 63
Petricevich, V. L. (2006) · Mediators of Inflammation · doi:10.1155/mi/2006/54273 · Cited by 62
Qin, C., He, B., Dai, W., Zhang, H., Wang, X., Wang, J., Zhang, X., Wang, G., Yin, L., & Zhang, Q. (2014) · Molecular Pharmaceutics · doi:10.1021/mp400691z · Cited by 61
Zhao, Y., Cai, X., Ye, T., Huo, J., Liu, C., Zhang, S., & Cao, P. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23166 · Cited by 61
Human astrocytoma cells express a unique chloride current
Ullrich, N. J., Gillespie, G. Y., & Sontheimer, H. W. (1996) · Neuroreport · doi:10.1097/00001756-199604100-00013 · Cited by 58
Petricevich, V. L., Cruz, A. H., Coronas, F. I. V., & Possani, L. D. (2007) · Toxicon · doi:10.1016/j.toxicon.2007.06.001 · Cited by 57
Self-citationPotent pleiotropic anti-angiogenic effects of TM601, a synthetic chlorotoxin peptide.
Jacoby, D. B., Dyskin, E., Yalçın, M., Kesavan, K. P., Dahlberg, W. K., Ratliff, J., Johnson, E. W., & Mousa, S. A. (2010) · PubMed · Cited by 54
Díaz-García, A., Morier-Díaz, L., Frión-Herrera, Y., Rodríguez-Sánchez, H., Lorenzo, Y. C., Llanes, D. M., Garlobo, Y. R., & Castro, J. A. F. (2013) · PubMed Central · Cited by 53
Quantum dot mediated imaging of atherosclerosis
Jayagopal, A., Su, Y. R., Blakemore, J. L., Linton, M. F., Fazio, S., & Haselton, F. R. (2009) · Nanotechnology · doi:10.1088/0957-4484/20/16/165102 · Cited by 51
Immune cells recruitment and activation by Tityus serrulatus scorpion venom
Fialho, E. M. S., Maciel, M. C. G., Silva, A. C. B., Reis, A. S., Assunção, A. K. M., Fortes, T. S., Silva, L. A., Guerra, R. N. M., Kwasniewski, F. H., & do Nascimento, F. R. F. (2011) · Toxicon · doi:10.1016/j.toxicon.2011.08.006 · Cited by 49
Shao, J., Cui, Y., Zhao, M., Wu, C., Liu, Y., & Zhang, J. (2013) · Peptides · doi:10.1016/j.peptides.2013.10.023 · Cited by 49
Hong, W., Zhang, R., Di, Z., He, Y., Zhao, Z., Hu, J., Wu, Y., Li, W., & Cao, Z. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.01.075 · Cited by 47
Parabutoporin, a cationic amphipathic peptide from scorpion venom: Much more than an antibiotic
Remijsen, Q., Verdonck, F., & Willems, J. (2009) · Toxicon · doi:10.1016/j.toxicon.2009.10.027 · Cited by 44
The many futures for cell-penetrating peptides: how soon is now?
Howl, J., Nicholl, I. D., & Jones, S. (2007) · Biochemical Society Transactions · doi:10.1042/bst0350767 · Cited by 41
Enhanced antimicrobial activity of novel synthetic peptides derived from vejovine and hadrurin
Sánchez-Vásquez, L., Silva-Sánchez, J., Jiménez-Vargas, J. M., Rodríguez‐Romero, A., Muñóz-Garay, C., Rodríguez, M. C., Gurrola, G. B., & Possani, L. D. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.01.028 · Cited by 36
Self-citationChlorotoxin-Fc Fusion Inhibits Release of MMP-2 from Pancreatic Cancer Cells
El‐Ghlban, S., Kasai, T., Shigehiro, T., Yin, H. X., Sekhar, S. C., Ida, M., Sánchez, A., Mizutani, A., Kudoh, T., Murakami, H., et al. (2014) · BioMed Research International · doi:10.1155/2014/152659 · Cited by 36
Cationic peptides from scorpion venom can stimulate and inhibit polymorphonuclear granulocytes
Willems, J., Noppe, W., Moerman, L., van der Walt, J., & Verdonck, F. (2002) · Toxicon · doi:10.1016/s0041-0101(02)00183-6 · Cited by 36
Antimicrobial peptides from scorpion venom induce Ca2+ signaling in HL-60 cells
Moerman, L., Verdonck, F., Willems, J., Tytgat, J., & Bosteels, S. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.09.175 · Cited by 28
Cell Penetration Properties of a Highly Efficient Mini Maurocalcine Peptide
Tisseyre, C., Bahembera, E., Dardevet, L., Sabatier, J., Ronjat, M., & WAARD, M. M. D. (2013) · Pharmaceuticals · doi:10.3390/ph6030320 · Cited by 25
Remijsen, Q., Berghe, T. V., Parthoens, E., Asselbergh, B., Vandenabeele, P., & Willems, J. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0908525 · Cited by 24
Gupta, S. D., Halder, B., Gomes, A., & Gomes, A. (2013) · Life Sciences · doi:10.1016/j.lfs.2013.06.022 · Cited by 20
Quantitative evaluation of the cell penetrating properties of an iodinated Tyr-l-maurocalcine analog
Tisseyre, C., Ahmadi, M., Bacot, S., Dardevet, L., Perret, P., Ronjat, M., Fagret, D., Usson, Y., Ghezzi, C., & WAARD, M. M. D. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.03.017 · Cited by 19
Haldar, S., Gupta, S. D., Gomes, A., Giri, B., Dasgupta, S. C., Biswas, A., Mishra, R., & Gomes, A. (2009) · Toxicon · doi:10.1016/j.toxicon.2009.09.013 · Cited by 14
Administration de molécules actives dans les cellules
Poillot, C., & WAARD, M. M. D. (2011) · médecine/sciences · doi:10.1051/medsci/2011275019 · Cited by 14
Outside the Box—Novel Therapeutic Strategies for Glioblastoma
Mrugała, M. M., Adair, J. E., & Kiem, H. (2012) · The Cancer Journal · doi:10.1097/ppo.0b013e318243f785 · Cited by 13
Cited by
Bordon, K. D. C. F., Cologna, C. T., Fornari-Baldo, E. C., Pinheiro-Júnior, E. L., Cerni, F. A., Amorim, F. G., Anjolette, F. A. P., Cordeiro, F. A., Wiezel, G. A., Cardoso, I. A., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01132 · Cited by 303
Metadata
- Authors
- Ortiz, E., Gurrola, G. B., Schwartz, E. F., & Possani, L. D.
- Venue
- Toxicon
- Publisher
- Elsevier BV
- Published
- 2015-01
- Volume
- 93
- Pages
- 125-135
- ISSN
- 0041-0101 (ISSN-L)
- OpenAlex
- W2055187724
- Cited by
- 335
- References
- 117
- FWCI
- 14.46
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.